Milestone for Biowin’s Rapid COVID-19 Nucleic Acid Detector

Nasdaq-listed Shineco, Inc to acquire 73.7% stake in Changzhou Biowin Pharmaceutical Changzhou Biowin Pharmaceutical Co., Ltd. ("Biowin"), a Chinese biotech company focusing on diagnostic product...

Waterdrop unveils Latest Reverse Osmosis Water Filtration System for Amazon Prime Day

Waterdrop, with continuous innovation and a passion for perfection, unveiled its latest Reverse Osmosis Water Filtration System at the Amazon Prime Day 2020. The...

Broncus Holding Corporation Closed Series D Financing

Broncus Holding Corporation, a global leader in diagnostic and therapeutic technology for lung diseases, announced today the closing of a Series D round of...

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan

TrialWire™, the most secure digital Patient Recruitment Platform, announces the launch of StudyBoost, the monthly insurance plan that provides an instant patient recruitment boost...

노보텍, 서울대병원 소화기내과 간파트와 업무 협약 체결

서울 - (ACN Newswire) - 아시아태평양 전문 임상시험수탁기관(CRO) 노보텍은 서울대병원 소화기내과 간파트와 임상시험을 위한 업무 협약(MOU)을 체결했다고 밝혔다. 아시아태평양지역에 강점을 둔 CRO인 노보텍은 임상시험 수행에 우수한 연구역량을 보유한...

Global BioLife Inc.’s Naturally Modified Sugar Laetose(TM) Unveiled at Harvard Global Health Summit

SGX-listed Singapore eDevelopment Ltd ("SeD", SGX:40V) is pleased to announce the results of clinical trials conducted on Laetose(TM), a low-glycemic, naturally modified sugar, developed...

Phar-East 2020 Names Keynote Speakers

SINGAPORE, Jan 20, 2020 - (ACN Newswire) - Covering innovation, digital, drug development and pharma we welcome leading lights from Pfizer, Bayer, Aslan Pharmaceuticals, Experimental Drug Development Centre...

美国胃肠内镜学会(ASGE)发布针对新型冠状病毒肺炎(COVID-19)时代内窥镜检查机构的相关建议

美国胃肠内镜学会(ASGE)在其署名刊物the Gastrointestinal Endoscopy (GIE)杂志上发表了一篇重要的文章。这篇题为《COVID-19爆发:内窥镜科应该知道什么》(Coronavirus (COVID-19) Outbreak: What the Department of Endoscopy Should Know)的文章是由ASGE会员Alessandro Repici博士和他的同事撰写的,他们有第一手的临床经验,目前仍身处意大利COVID-19的危机中。 内窥镜检查要求患者和医生近距离接触,医生在检查过程中,尤其是在做上消化道(GI)内窥镜检查时,会接触到飞溅物、粘液或唾液。此外,粪口传播已被认定是COVID-19的潜在传播途径。内窥镜室也是一个人群(工作人员、病人、护理人员、亲属等)高度集中的地方。因此,建立详细而严格的规则对于保护医护人员和患者都至关重要。 即使内窥镜科的医护人员没有直接参与COVID-19阳性患者的诊断和治疗评估,内镜检查仍应被视为一种危险的操作。实际上,对于患呼吸系统疾病患者而言,这种暴露风险以及随后感染内窥镜医护人员的可能性是很大的,因为这些疾病可以通过空气传播。 考虑到最近在活检标本和粪便中检测到SARS冠状病毒,这表明可能存在粪口传播,因此内窥镜医护人员的暴露风险也不限于上内窥镜检查过程。鉴于无症状患者在潜伏期也可能会传播病毒,其相关性会更大。 在内窥镜科制定感染预防措施和操作指南对于打造高质量和极其安全的环境,以保护患者和医务人员至关重要。在这个COVID-19爆发的新时代,必须实施和维护这些措施,以避免疾病进一步传播。 “我们认识到ASGE成员及其世界各地的患者在保持个人健康的同时,还应努力减少对日常的内窥镜检查操作和整个区域经济的干扰和破坏。” ASGE总裁、医学博士John Vargo表示,“对全世界来说,这都是一个充满挑战的时期,内窥镜医师和医生们还额外肩负着保护病人和自身健康的职责。” 阅读GIE 文章。https://pr.report/IWK3r6dG ASGE非常感谢作者与世界各地其他的医疗专家分享他们的第一手经验。虽然他们目前正在各自所属的医疗机构为危重病人提供护理,但是他们都一致认为分享相关知识以尽量减少这次疫情对全球影响意义重大。 于美国胃肠内镜学会 自1941年成立以来,美国胃肠内镜学会(ASGE)一直致力于通过促进胃肠内窥镜的发展和创新来提升病人的护理水平和消化系统健康。ASGE在全球拥有15000多名会员,一直致力于推动内窥镜培训和实践的最高标准,促进内窥镜研究,对内窥镜领域的杰出贡献进行认证,并且是内窥镜教育首屈一指的资源来源。请访问www.asge.org 和www.screen4coloncancer.org获取更多信息,并在您所在的地区找到一位有资质的合格医生。 欲了解更多信息,请联系: Andrea Lee Director of Marketing and Communications American Society for...

MicroPort CardioFlow Completes Raising New Round of Funds

On April 15, 2020, MicroPort Scientific Corporation (Stock code: 00853) ("MicroPort"), announced that MicroPort CardioFlow Medtech Corporation ("MicroPort CardioFlow"), which is a subsidiary of...

Favored by Capital Market Again, MicroPort’s CRM Business Brings in New Investor

Thanks to capital market's growing expectation for the aging population and accelerated substitution of imported medical devices, China's medical devices industry has entered a...

Sihuan Pharmaceutical Launched an Equity Incentive Plan to Inject New Impetus for the Company’s...

Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") announced that on 26 August 2020,...

Jacobson Pharma Announces FY2021 Interim Results

Declares Interim Dividend of HK0.8 Cents Per Share Harnesses Robust Portfolio to Drive Growth Momentum Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company";...

Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and...

Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, and Iterion Therapeutics, Inc., a venture-backed,...

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to...

Scivita Medical Technology Co., Ltd. ("civita Medical) today announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become...

Creso Pharma Gears Up for Adult-Use Market with New Supply Agreement — CFN Media

SEATTLE, WA - (ACN Newswire) - via NEWMEDIAWIRE -- CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis...

Sino Biopharmaceutical Announces 2019 First Quarterly Results

Revenue Up 33.4% to RMB6,208 Million Underlying Profit* Climbs 22.4% to RMB976 Million Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the...

EuroEyes, UMH Jointly Develop Ophthalmological Services in Mainland China, HK

EuroEyes International Eye Clinic Limited, one of the leading brands in the vision correction industry known for German ophthalmology excellence, announced that EuroEyes Group...

Malaysians Rush for Anti-Virus Sanitiser, NatShield(TM), after Pharmacies Restock on Concerns of Spread of...

Amidst growing concerns of infection by the Wuhan coronavirus, Malaysians queued up today at local pharmacies to stock up on a handheld NatShield(TM) sanitizer...

澳大利亞CRO, Avance Clinical公司在COVID-19疫苗和臨床試驗治療方案方面具有得天獨厚的優勢

澳大利亞CRO Avance Clinical今天表示,澳大利亞快速的監管審批環境,關鍵意見領袖的專業知識和高質量的臨床研究中心,以及頗具吸引力的40%的政府臨床試驗支出退稅,所有這一切都意味著Avance具有得天獨厚的優勢,能夠使緊迫的COVID-19試驗速見成效。 澳大利亞CRO Avance Clinical今天表示,澳大利亞快速的監管審批環境,關鍵意見領袖的專業知識和高質量的臨床研究中心,以及頗具吸引力的40%的政府臨床試驗支出退稅,所有這一切都意味著Avance具有得天獨厚的優勢,能夠使緊迫的COVID-19試驗速見成效。 Avance Clinical在CRO領域擁有20年的經驗,並在過去5年中一直在進行疫苗和傳染病試驗。 Avance顯然是針對COVID-19試驗的首選CRO。 Avance Clinical首席執行官Yvonne Lungershausen表示:“重要的是,澳大利亞政府提供了超過40%的研發現金退稅,再加上當前匯率頗具吸引力。這使得澳大利亞成為進行臨床試驗最划算的地區之一。” 澳大利亞一向以卓越的科研實力,先進的醫療保健水平以及在臨床試驗競爭較少的環境中擁有更多招募病人的機會而著稱,這進一步鞏固了其作為當前COVID-19試驗地點的優勢。 Avance的首席戰略官Ben Edwards表示:“我們公司在該領域的專業技術和知識深度使我們成為任何尋求研發COVID-19療法的生物技術公司的首選CRO。” “另外值得特別強調的一點是,根據目前的趨勢,澳大利亞可能是受COVID-19影響最小的國家之一。” 我們預計,在整個世界適應COVID-19疫情的這段時間內,這一點可以使其對臨床試驗活動的干擾降到最低。 ” Lungershausen女士表示,總體而言,我們預計公司目前管理的所有治療適應症項目的進展和時間表都不會受到重大干擾。她說:“我們團隊與遠程客戶和臨床服務提供商合作的經驗以及我們的虛擬通信系統和流程使我們在保持當前項目發展勢頭方面處於明顯優勢。” “我們的團隊對項目的遠程通信和管理已經是駕輕就熟了,” Edwards先生說。 澳大利亞的臨床研究機構已經對COVID-19流行病所帶來的挑戰做出了響應,實施了多項旨在保護患者和公眾利益的措施和製度,同時還力求最大程度地減少對臨床研究活動的干擾。 Avance臨床運營團隊與試驗地點不間斷地溝通,接收有關程序不斷更新變化的最新信息,並有效管理與Avance所轄項目有關的活動。 “Avance Clinical擁有一系列可用的工具對中心和客戶提供支援,在這一頗具挑戰性的時期成功完成他們的試驗。這些都將被仔細管理,以確保研究的合規性,” Lungershausen女士說。 想了解更多關於在澳大利亞開展您下一項研究的優勢,請聯繫我們: https://www.avancecro.com/contact-us/ 關於 Avance Clinical Avance Clinical擁有20多年的從業經驗,目前是澳大利亞領先的合同研究機構之一。 Avance Clinical通過協調人員、技能和專業知識,促進高質量的藥物開發,以追求更健康的世界。 AvanceClinical憑藉其經驗豐富的團隊,致力於提供高質量的臨床研究服務。 Avance Clinical的知識和經驗庫也得益於精心挑選的專家在不斷地擴張,這些專家也表現出對所選領域的高度熱情。 Avance Clinical在成熟的臨床試驗生態系統中提供高質量的服務,包括世界級的研究人員和能夠訪問特定患者組群的中心。其他好處還包括: - 在澳大利亞各地使用獨立的一期設施,包括醫院內部設立的重症護理中心 - 致力於臨床研究的專業研究人員 -...

Agilex Biolabs Presents the Australian Advantage, including the World’s Largest Rebate on Clinical Trial...

Agilex Biolabs, Australia's largest specialist bioanalytical laboratory for biotech clinical trials, is presenting the Australian Advantage including the world's most attractive rebate on clinical...

Lotto Results

Ultra Lotto 6/58 result

6/58 Ultra Lotto Result Today and Winning Number History from PCSO

METRO MANILA - May 16, 2021 - Ultra Lotto 6/58 has the biggest initial jackpot in all of the games of Philippine Charity Sweepstakes...
6/49 Super Lotto Result Today

6/49 Super Lotto Result Today and Winning Numbers History from PCSO

MANILA - May 16, 2021 - Check your tickets here! Know the latest 6/49 Super Lotto Result Today based on the official draw of...
2D Lotto Big

2D Lotto Result Today and Previous Results from PCSO

MANILA - May 16, 2021 - Here are the 2D Ez2 Lotto result for today from the Philippine Charity Sweepstakes Office (PCSO). PCSO releases...
3D Lotto Big

3D Lotto Result Today and Past Results Summary (Swertres) from PCSO

MANILA, Philippines - May 16, 2021 - Looking for 3D Swertres Lotto result today for the 2PM, 5PM, and 9PM draws? Here are the...
6/55 Grand Lotto Result

6/55 Grand Lotto Result Today and Past Results Summary from PCSO

METRO MANILA - May 15, 2021 - Here is the PCSO 6/55 Grand Lotto Result Today. Check your lottery tickets and see if you’ve...